Skip to content

Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management

Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07780916
Enrollment
200
Registered
2026-08-24
Start date
2025-12-03
Completion date
2027-02-01
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, GLAUCOMA 1, OPEN ANGLE, D (Disorder), Glaucoma Eye, Glaucoma Following Surgery, Glaucoma Patient

Keywords

Ab-interno trabeculotomy, Trabectome, Minimally invasive glaucoma surgery, MIGS, Intraocular pressure, Long-term outcomes, Trabecular meshwork, Glaucoma surgery

Brief summary

Glaucoma is one of the leading causes of irreversible vision loss worldwide. Elevated intraocular pressure (IOP) is the most important risk factor for the development and progression of the disease. Ab-interno trabeculotomy (AIT) using the Trabectome system is a minimally invasive glaucoma surgery (MIGS) that reduces aqueous humor outflow resistance by ablating the trabecular meshwork and the inner wall of Schlemm's canal, thereby lowering intraocular pressure. Previous studies have demonstrated good short-term efficacy of this procedure. However, robust long-term data spanning several years remain scarce. The aim of this study is to evaluate the long-term outcomes of AIT in glaucoma patients who underwent surgery between 2019 and 2021 at the Department of Ophthalmology, University Hospital Würzburg. Patients are invited for a single study visit at which intraocular pressure, visual acuity, anterior chamber angle by gonioscopy, and optic nerve structure by optical coherence tomography (OCT) are assessed. The collected data are compared with pre-operative baseline values obtained from medical records. The results are intended to improve the assessment of long-term surgical success and to optimize patient selection for this procedure in the future.

Detailed description

Glaucoma is a progressive optic neuropathy in which elevated intraocular pressure (IOP) represents the primary modifiable risk factor. Ab-interno trabeculotomy (AIT) with the Trabectome is a minimally invasive glaucoma surgery (MIGS) that reduces IOP by ablating the trabecular meshwork and inner wall of Schlemm's canal, thereby improving aqueous humor outflow. Previous studies have demonstrated favorable short-term IOP reduction and a good safety profile. However, robust long-term data evaluating sustained surgical success, disease progression, and the need for additional interventions over multiple years are currently lacking. This single-center, observational study with a retrospective pre-operative baseline and a prospective cross-sectional follow-up visit addresses this knowledge gap. Patients who underwent AIT at the Department of Ophthalmology, University Hospital Würzburg, are contacted and invited for a single study visit of approximately 30 minutes. At this visit, the following assessments are performed: * Medical history review since the time of surgery * Visual acuity assessment * Goldmann applanation tonometry (IOP measurement) * Slit-lamp biomicroscopy including gonioscopy for the anterior chamber angle * Optical coherence tomography (OCT) of the optic nerve head and retinal nerve fiber layer (RNFL) All examinations are non-invasive, painless, and consistent with routine ophthalmic care. No additional follow-up visits are required beyond this single study contact. Pre-operative data, including baseline IOP, glaucoma diagnosis, medication use, and surgical details are obtained from existing medical records. These are compared with findings at the study visit to evaluate long-term treatment success. The study is initiated and funded by the Department of Ophthalmology, University Hospital Würzburg. No external funding or industry sponsorship is involved. The study has been approved by the responsible Ethics Committee with no objections raised. Approximately 180 participants are planned for enrollment. Data are pseudonymized and stored on password-protected servers. No data transfer to third parties or outside the European Union is performed. Data will be deleted no later than 10 years after study completion.

Interventions

PROCEDUREAb-interno trabeculotomy

Ab-interno trabeculotomy (AIT) is a minimally invasive glaucoma surgery (MIGS) performed using the Trabectome device. The procedure ablates the trabecular meshwork and the inner wall of Schlemm's canal via an ab-interno approach, thereby reducing resistance to aqueous humor outflow and lowering intraocular pressure. The surgery is performed under local or general anesthesia and can be combined with cataract surgery. In this observational study, the intervention was performed prior to study enrollment; no surgical intervention is performed as part of the study itself.

Sponsors

Wuerzburg University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of glaucoma * Previous ab-interno trabeculotomy (AIT) using the Trabectome device performed at the Department of Ophthalmology, University Hospital Würzburg * Surgery performed between 2019 and 2021 * Ability to provide written informed consent * Age ≥ 18 years at time of surgery

Exclusion criteria

* Inability to attend the study visit * Withdrawal of informed consent * Insufficient medical records for pre-operative baseline data retrieval

Design outcomes

Primary

MeasureTime frameDescription
Change in Intraocular Pressure (IOP) from Pre-operative Baseline to Follow-upFrom pre-operative baseline to single follow-up visit (minimum 4 years, up to 10 years post-surgery)Mean intraocular pressure (mmHg) measured by Goldmann applanation tonometry at the study visit, compared to pre-operative baseline IOP obtained from medical records. Surgical success is defined as IOP reduction of ≥20% from baseline and/or IOP ≤18 mmHg, with or without anti-glaucomatous medication.

Secondary

MeasureTime frameDescription
Visual Acuity at Follow-upAt single follow-up visit (minimum 4 years, up to 10 years post-surgery)Visual acuity assessed using standardized visual acuity charts at the study visit. Results are recorded in decimal notation and converted to logMAR for analysis. Pre-operative VA is obtained from medical records for comparison.
Peripapillary Retinal Nerve Fiber Layer (RNFL) Thickness as Measured by Optical Coherence Tomography (OCT)At single follow-up visit (minimum 4 years, up to 10 years post-surgery)Peripapillary RNFL thickness (µm) assessed by spectral- domain optical coherence tomography (SD-OCT) at the study visit. Global and sectoral RNFL values are recorded. Results are compared to pre-operative OCT data from medical records where available, to evaluate structural progression of glaucomatous optic neuropathy.
Change in Number of Intraocular Pressure-Lowering Medications from Pre-operative Baseline to Follow-upFrom pre-operative baseline to single follow-up visit (minimum 4 years, up to 10 years post-surgery)Total number of topical and systemic anti-glaucomatous medications used by the patient at the time of the study visit, compared to the number documented in medical records prior to surgery. Reduction in medication burden is considered an additional indicator of surgical success.
Rate of Surgical Failure Requiring Additional IOP-Lowering Intervention After Ab-Interno TrabeculotomyFrom date of surgery to single follow-up visit (minimum 4 years, up to 10 years post-surgery)Proportion of patients who required additional surgical or laser intervention (e.g., trabeculectomy, tube shunt implantation, selective laser trabeculoplasty) due to insufficient IOP control following AIT. Data obtained retrospectively from medical records. Surgical failure is defined as the need for re-intervention at any time point after the primary procedure.

Countries

Germany

Contacts

CONTACTRaoul Verma-Führing, Dr.
augenklinik@ukw.de+49 931 20120458
CONTACTEric Schreiner
ericschreiner03studium@gmail.com
PRINCIPAL_INVESTIGATORRaoul Verma-Führing, Dr.

Wuerzburg University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026